XPH News and Press, SPDR S&P Pharmaceuticals From 04/20/23

2023-04-20 23:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Amphenol Corporation (NYSE: APH) today released its 2022 Sustainability Report. “Amphenol continues to strengthen our commitment to corporate sustainability across our organization, all while delivering exceptional performance for our shareholders,” said Amphenol President and C...

2023-04-17 10:30:00 ET Summary The joint stock-bond rally this year has put renewed focus on portfolio construction approaches. We think a new macro regime needs a new approach. U.S. stocks rose last week but lost steam on Friday on the market partly pricing out potential rate cut...

2023-04-11 08:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-04-04 23:52:36 ET Summary XPH gives you exposure to a broad-based cut of the US Pharmaceuticals sector. Patent expirations are a major headwind affecting many companies in the industry. Focus on orphan drug development leads to riskier revenue streams. Overall, XPH is...

2023-04-01 17:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-03-31 14:13:06 ET Summary Merck & Co has more than 60 drugs and projects in clinical development, a robust balance sheet, and free cash flow. We believe earnings and revenue will continue to grow, driving the share price up perhaps 30% or more over the next 12 months. ...

Amphenol Corporation (NYSE: APH) announced today the pricing of its offering of $350,000,000 aggregate principal amount of senior notes due 2026 (the “Notes”). The Notes will have an interest rate of 4.750% per annum. The closing of the offering is expected to occur on March 30, 202...

2023-03-24 03:00:00 ET Summary We remain selective in taking risk as macro factors continue to drive sentiment. Despite the uncertainties, investors should not lose sight of equities’ enduring role in a well-balanced portfolio. We advocate a near-term focus on resilienc...

2023-03-22 08:54:00 ET Summary Technology and healthcare are good examples of sectors that can play different equity-allocation roles than you might expect. Unlike income-oriented defensive sectors, which are sensitive to changes in interest rates, some of the highest-quality low-...